Skip to main content

Alecnib 150 mg ( Alectinib)

Understanding who manufactures a medicine is an important part of making an informed healthcare decision. Manufacturer information helps patients, caregivers, pharmacists, and healthcare professionals identify the company responsible for producing a medicine and assess the information provided with the product.

Alecnib is identified on this website as a product containing alectinib, with a stated strength of 150 mg. Alectinib is an anticancer medicine belonging to a group of medicines known as anaplastic lymphoma kinase (ALK) inhibitors. It is used for specific patients with ALK-positive non-small cell lung cancer (NSCLC).

However, the manufacturer of Alecnib itself has not been independently verified for this website. Therefore, we do not attribute Alecnib to a particular pharmaceutical company without reliable product-specific documentation.

Alecnib Manufacturer Information

The company responsible for manufacturing a medicine should be identified through the product’s official packaging and accompanying documentation.

For Alecnib 150 mg, the following details should be checked against the actual product:

Product detailInformation
Product nameAlecnib
Stated strength150 mg
Active ingredientAlectinib
Medicine categoryAnticancer medicine
Drug classALK tyrosine kinase inhibitor
ManufacturerRequires confirmation from product packaging
Marketing authorization holderRequires product-specific verification
Manufacturing countryRequires product-specific verification
Registration detailsDepend on the country and product

The manufacturer, marketing authorization holder, distributor, and importer may be different companies. These roles should not be treated as interchangeable.

Understanding the Alectinib Manufacturer

Alectinib is an established targeted cancer medicine developed for the treatment of ALK-positive non-small cell lung cancer.

The reference brand Alecensa is associated with Roche and Genentech in relevant markets. However, this association does not establish that either company manufactures Alecnib.

Different pharmaceutical companies may manufacture or distribute products containing the same active ingredient. Their products may have different brand names, packaging, regulatory status, and approved markets.

For this reason, patients and healthcare professionals should check the specific manufacturer information printed on the Alecnib package rather than assuming that it is the same as the manufacturer of another alectinib brand.

What Does a Pharmaceutical Manufacturer Do?

A pharmaceutical manufacturer is responsible for producing medicines according to applicable manufacturing and quality requirements.

Depending on the product and the company’s role, its responsibilities may include:

1. Manufacturing the medicine

The manufacturing company produces the medicine using the specified active pharmaceutical ingredient and other formulation components. It must follow applicable production procedures and quality requirements.

2. Quality control

Quality-control procedures help assess whether a medicine meets its established specifications. These may include checks involving identity, strength, purity, uniformity, and other relevant quality characteristics.

3. Packaging and labeling

Medicines must be packaged and labeled with appropriate product information. Packaging may identify the product name, strength, batch number, manufacturing details, expiry date, storage instructions, and other required information.

4. Batch traceability

Batch or lot numbers help identify individual production batches. This information is important for quality investigations, product recalls, and other safety-related activities.

5. Regulatory compliance

Pharmaceutical manufacturers must meet the applicable requirements of the countries in which their products are manufactured or marketed. Requirements vary between regulatory jurisdictions.

How to Identify the Actual Manufacturer of Alecnib

Patients and healthcare professionals should use the physical product packaging and official product documents to identify the company responsible for Alecnib.

The following information can help:

  • Manufacturer name: Check the company identified as the manufacturer on the carton or package insert.
  • Manufacturing address: Review the stated manufacturing site or company address.
  • Batch number: Confirm that the batch or lot number is clearly printed.
  • Manufacturing and expiry dates: Check the dates and ensure that the product is within its stated shelf life.
  • Marketing authorization information: Review the registration or authorization details where applicable.
  • Product leaflet: Compare the information in the leaflet with the product name and strength on the packaging.

If the packaging does not clearly identify the manufacturer, ask a licensed pharmacist or the relevant pharmaceutical company for clarification.

Manufacturer, Distributor, and Marketing Authorization Holder: What Is the Difference?

These terms describe different roles in the pharmaceutical supply chain.

TermMeaning
ManufacturerThe company or facility responsible for producing the medicine.
Marketing authorization holderThe company or organization holding the relevant product authorization in a particular market.
DistributorThe business responsible for supplying or distributing the medicine.
ImporterThe company responsible for importing the product into a country, where applicable.
Retail pharmacyThe licensed pharmacy or seller that supplies the medicine to patients.

One company may perform several of these roles, but this should not be assumed without documentation.

Why Manufacturer Information Matters

Manufacturer transparency is important for several reasons.

Product identification: It helps distinguish between medicines with similar names or the same active ingredient.

Quality assessment: It allows healthcare professionals and patients to identify the responsible company and review available product documentation.

Traceability: Manufacturer and batch details can help trace a product if a quality concern or recall occurs.

Regulatory checks: Manufacturer information can help establish whether a medicine is registered or authorized for sale in a particular country.

Patient safety: Correct product identification reduces the risk of confusion between different medicines, strengths, or formulations.

Is Alecnib Manufactured by Roche or Genentech?

The manufacturer of Alecnib has not been independently confirmed for this website. Although Roche and Genentech are associated with the reference alectinib brand Alecensa in relevant markets, this does not prove that they manufacture Alecnib.

Patients should not assume that Alecnib and Alecensa have the same manufacturer, regulatory status, formulation, or product characteristics.

The correct manufacturer should be identified using the actual Alecnib packaging and applicable product documentation.

How to Check Alecnib Product Authenticity

Manufacturer information is one part of product verification. It should be considered together with packaging details, batch information, and the medicine’s regulatory status.

Before using Alecnib, consider the following checks:

  1. Confirm that the product name and stated strength match the prescription.
  2. Check the manufacturer’s name and address on the packaging.
  3. Examine the packaging for damage, unusual alterations, or signs of tampering.
  4. Check the batch or lot number and expiry date.
  5. Review the patient information leaflet supplied with the medicine.
  6. Confirm the product’s registration status through the relevant national regulatory authority when applicable.
  7. Obtain the medicine through a legally authorized and appropriately licensed supply channel.

A professional should investigate any inconsistencies in the packaging or product information before the medicine is used.

Important Information for Patients and Healthcare Professionals

Alecnib is identified on this website as alectinib 150 mg. However, the product’s manufacturer, manufacturing site, marketing authorization holder, and country-specific regulatory status require confirmation from reliable product documentation.

Alectinib is a prescription anticancer medicine. It should only be used under the supervision of a qualified oncology professional.

The fact that two products contain alectinib does not automatically establish that they are interchangeable. Healthcare professionals should assess the exact product, formulation, approved status, and prescription before recommending a substitution.

Patients should not change their cancer treatment or replace a prescribed medicine based only on similarities in product names or active ingredients.

Frequently Asked Questions About the Alecnib Manufacturer

Who manufactures Alecnib 150 mg?

The manufacturer of Alecnib 150 mg has not been independently verified for this website. The manufacturer’s name should be confirmed using the actual product packaging and official documentation.

Is Alecnib manufactured by Roche?

There is no independently verified product-specific information establishing Roche as the manufacturer of Alecnib. Roche is associated with the reference alectinib brand Alecensa in relevant markets, but that does not establish Alecnib’s manufacturer.

Is Alecnib the same as Alecensa?

Both names are associated with alectinib information in this context, but they should not automatically be considered identical products. Their manufacturers, formulations, regulatory status, and product documentation must be checked separately.

Why should I check the manufacturer before using Alecnib?

Manufacturer information helps identify the company responsible for producing the medicine. It also supports product traceability, quality investigations, and verification of product documentation.

Where can I find the manufacturer name?

The manufacturer name is generally provided on the medicine’s outer carton, packaging label, or accompanying product leaflet. If the information is unclear, consult a licensed pharmacist or the relevant pharmaceutical company.

Does the distributor have to be the manufacturer?

No. A distributor supplies or distributes the medicine, while the manufacturer is responsible for producing it. These may be separate companies.

Final Information About the Alecnib Manufacturer

Manufacturer transparency is an important part of responsible medicine information. Alecnib is identified on this website as alectinib 150 mg, an anticancer medicine associated with the treatment of specific ALK-positive lung cancers.

The manufacturer of Alecnib has not been independently confirmed here. Patients and healthcare professionals should therefore rely on the actual product packaging, official documentation, and relevant regulatory records when identifying the responsible company.

Accurate manufacturer identification, appropriate product verification, and professional medical supervision are important when using prescription anticancer medicines.

Medical Information Notice: This page provides general product and manufacturer information. It does not confirm the manufacturer, authenticity, regulatory approval, or quality of any individual Alecnib product. Always consult a qualified healthcare professional before using alectinib.